Support The Moscow Times!

Dr. Reddy Could Acquire Dr. Mom

Dr. Reddy's Laboratories, India's second-biggest drugmaker by revenue, is looking to acquire medicine brands in Russia, chief financial officer Umang Vohra said.

Russia, Dr. Reddy's third-biggest market, generated sales of $201 million in the year ended March 31, including prescription medicines and over-the-counter remedies. The company wants to increase sales from over-the-counter medications, which account for half of Russia's pharmaceutical market, Vohra said in Hyderabad, where the drugmaker is based.

Dr. Reddy's sells Senade laxative and Nise pain-relieving gel without a prescription in Russia. The manufacturer may buy Doktor Mom, a cough medicine brand in Russia, from Mumbai-based J.B. Chemicals & Pharmaceuticals, the Business Standard reported May 10, citing people it did not identify.

The expansion may involve "brand acquisitions and in-licensing," Vohra said.

Fiscal fourth-quarter net income doubled to 3.35 billion rupees ($74.6 million) from 1.67 billion rupees a year earlier, the company said Friday. Sales rose 23 percent to 20.2 billion rupees on growth in Russia and the United States.

Dr. Reddy's rose 3.3 percent, the most since Jan. 31, to 1,651.65 rupees at the 3:30 p.m. close of trading in Mumbai on Friday. The gain beat the 1.1 percent increase in the Bombay Stock Exchange's Benchmark Sensitive Index.

… we have a small favor to ask. As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more